<code id='8AAC01ACC0'></code><style id='8AAC01ACC0'></style>
    • <acronym id='8AAC01ACC0'></acronym>
      <center id='8AAC01ACC0'><center id='8AAC01ACC0'><tfoot id='8AAC01ACC0'></tfoot></center><abbr id='8AAC01ACC0'><dir id='8AAC01ACC0'><tfoot id='8AAC01ACC0'></tfoot><noframes id='8AAC01ACC0'>

    • <optgroup id='8AAC01ACC0'><strike id='8AAC01ACC0'><sup id='8AAC01ACC0'></sup></strike><code id='8AAC01ACC0'></code></optgroup>
        1. <b id='8AAC01ACC0'><label id='8AAC01ACC0'><select id='8AAC01ACC0'><dt id='8AAC01ACC0'><span id='8AAC01ACC0'></span></dt></select></label></b><u id='8AAC01ACC0'></u>
          <i id='8AAC01ACC0'><strike id='8AAC01ACC0'><tt id='8AAC01ACC0'><pre id='8AAC01ACC0'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:447
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          With clinical trial data readouts, here's how to spot spin
          With clinical trial data readouts, here's how to spot spin

          AdobeInvestors,analysts,doctors,andevenpatientsfaceanavalancheofnewsfrombiotechcompaniesabouttheirhu

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          New Alzheimer's drugs heat up race for early detection blood tests

          MarionBerard/AFP/GettyImagesWiththeadventofdisease-modifyingAlzheimer’sdrugs,everyoneintheworldofAlz